Skip to content
zameds

Clioquinol, fluocinolone acetonide

Sold as Synalar-c, Cortoderm c

Combination product

This product contains more than one active ingredient, so it has no single molecular structure.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
2
Registrations
4

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Glenmark Pharmaceuticals South Africa (Pty) LtdSynalar-ccream, ointmentG1398, G1399Not determinedNone
Pharmacare limited û woodmeadCancelledCortoderm ccreamM0003, M0045Not determinedNone

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Synalar-c cream

EACH 1,0 g CREAM CONTAINS CLIOQUINOL A 30,0 mg FLUOCINOLONE ACETONIDE A 0,250 mg

CreamG1398Old MedicineNot determinedNone
Synalar-c ointment

EACH 1,0 g OINTMENT CONTAINS CLIOQUINOL A 30,0 mg FLUOCINOLONE ACETONIDE A 0,250 mg

OintmentG1399Old MedicineNot determinedNone
Cortoderm - c

EACH 5 g OINTMENT CONTAINS CLIOQUINOL 150 mg FLUOCINOLONE ACETONIDE 1,25 mg

-M0003M/13.4.1/3CancelledNot determinedNone
Cortoderm - c cream

EACH 5 g CREAM CONTAINS CLIOQUINOL 150 mg FLUOCINOLONE ACETONIDE 1,25 mg

-CreamM0045M/13.4.1/45CancelledNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Research articles

Loading...
Loading PubMed articles